Human GFAP ELISA Kit
$753.00
-
Product name
Human GFAP ELISA Kit
See all GFAP kits -
Detection method
Colorimetric - …
- One-wash 90 minute protocol
- Sensitivity: 47 pg/ml
- Range: 0.781 ng/ml – 50 ng/ml
- Sample type: Tissue Extracts
- Detection method: Colorimetric
- Assay type: Sandwich (quantitative)
- Reacts with: Human
Related products
-
Sale!
UncategorizedSARS-CoV-2 (COVID-19) IgG ELISA Kit
Original price was: $1,140.00.$1,089.00Current price is: $1,089.00. Add to cartSARS-CoV-2 (COVID-19) IgG is intended for the qualitative determination of IgG class antibodies against SARS-CoV-2 in human serum or plasma (citrate, heparin) to support the diagnosis of COVID-19 disease and constitutes a supplement to direct pathogen detection. In addition, serology can be used to collect epidemiological information on the prevalence of SARS-CoV-2.
-
UncategorizedHuman Tau ELISA Kit
$699.00 Add to cartKey features and details
- One-wash 90 minute protocol
- Sensitivity: 16 pg/ml
- Range: 40.63 pg/ml – 2600 pg/ml
- Sample type: Cell culture extracts, Cell culture media, EDTA Plasma, Hep Plasma, Serum, Tissue Extracts
- Detection method: Colorimetric
- Assay type: Sandwich (quantitative)
- Reacts with: Human
-
UncategorizedS100B ELISA Kit
$754.00 Add to cartKey features and details
- One-wash 90 minute protocol
- Sensitivity: 139 pg/ml
- Range: 0.31 ng/ml – 20 ng/ml
- Sample type: Tissue Extracts
- Detection method: Colorimetric
- Assay type: Sandwich (quantitative)
- Reacts with: Mouse, Rat, Human
-
UncategorizedIgM Antibody
$820.00 Add to cartThe IgM class of antibodies recognizes a large variety of pathogenic antigens and is highly active in cytotoxic and cytolytic reactions due to its superior activation of the complement system. IgM antibody has applications in Antibody Drug Discovery. Just a few reasons why IgM antibody can be an attractive therapeutic are listed below.
- IgM antibody can make a good biologic against cancer owing to its strong avidity as well as complement fixation property.
- For certain targets, particularly those such as glycol-epitopes on cancer cells, an IgM antibody might be the best approach.
- An IgM antibody might also be useful as a vaccine adjuvant, acting as soluble toll-like receptors through the formation of immune complexes with antigen.
- It has been suggested to use IgMs as preventive vaccine.
- The innate ability of IgM to mediate autoimmunity can be utilized to ameliorate graft rejections during transplantation procedures.
- The inflammatory control IgM antibody provides systemic exposure to self antigens could be harnessed to treat arthritis.
Recent advancements have made IgM antibody amenable to manipulation that allows further tuning of its effector function to meet the above therapeutic needs. There are several requirements for IgM antibodies to be considered as a potential standard platform, including in vitro optimization, recombinant production, and purification. IgM antibody variable chains have been manipulated using phage display technology in vitro to optimize IgM therapeutic antibody candidates. Their recombinant yields in cell culture have been improved and methods for purification have been optimized. Based on these advances an IgM therapeutics platform can be built.